Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$17,500.00
"Chemokine receptor CXCR3 biased signalling, heteromerization and decoy properties"
FY 2013-14
Summary
Numerous wide-spread autoimmune diseases, or diseases having an autoimmune component, afflict a large number of Canadians. The success of available treatment is often limited. New therapeutic strategies are thus warranted. Auto-immune diseases can affect many different organs systems, for example the lung, the brain, the intestine, or the skin, where they manifest as asthma, multiple sclerosis, inflammatory bowel disease or eczema. Common to these different diseases is that activated T-cells, normally combating infection, invade the afflicted tissue where they contribute to derailed immune reactions, which cause the symptomatic disease.
Chemokines are soluble immune mediators that guide motile immune cells into target tissues. They are detected by chemokine receptors that are expressed by the motile cells. Activated effector T-cells express high levels of the chemokine receptor CXCR3, and it is this receptor that is responsible for the invasion of diseased tissue. The overarching idea of our project is that successful pharmacological inhibition effector T-cells into target tissue will improve the symptoms of auto-immune diseases. Unfortunately, disappointing results of clinical trials illustrate that our knowledge of the mechanism by which CXCR3 guides T-cells to target tissue is as yet insufficient. For example, CXCR3 recognizes three different chemokine ligands, which we have shown to exert different functions. Moreover, heteromerization of CXCR3 with other chemokine receptors further complicates the picture. The aim of our study is the investigation of the different effects of the different CXCR3 ligands (biased agonism), in the context of CXCR3 homo- and heteromers.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311720
Name
Guité-Vinet François
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
"Chemokine receptor CXCR3 biased signalling, heteromerization and decoy properties"
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biased Signalling; Bioluminescence Resonance Energy Transfer; Chemokine; Chemokine Receptor; Cxcr3; Decoy Receptor; Heteromerization; Radio-Labelled Chemokine
Abstract
Numerous wide-spread autoimmune diseases, or diseases having an autoimmune component, afflict a large number of Canadians. The success of available treatment is often limited. New therapeutic strategies are thus warranted. Auto-immune diseases can affect many different organs systems, for example the lung, the brain, the intestine, or the skin, where they manifest as asthma, multiple sclerosis, inflammatory bowel disease or eczema. Common to these different diseases is that activated T-cells, normally combating infection, invade the afflicted tissue where they contribute to derailed immune reactions, which cause the symptomatic disease.
Chemokines are soluble immune mediators that guide motile immune cells into target tissues. They are detected by chemokine receptors that are expressed by the motile cells. Activated effector T-cells express high levels of the chemokine receptor CXCR3, and it is this receptor that is responsible for the invasion of diseased tissue. The overarching idea of our project is that successful pharmacological inhibition effector T-cells into target tissue will improve the symptoms of auto-immune diseases. Unfortunately, disappointing results of clinical trials illustrate that our knowledge of the mechanism by which CXCR3 guides T-cells to target tissue is as yet insufficient. For example, CXCR3 recognizes three different chemokine ligands, which we have shown to exert different functions. Moreover, heteromerization of CXCR3 with other chemokine receptors further complicates the picture. The aim of our study is the investigation of the different effects of the different CXCR3 ligands (biased agonism), in the context of CXCR3 homo- and heteromers.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Guité-Vinet, François
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~